top of page
SABCS 2022 - DEMONSTRATING CTCs' REAL-TIME IMPACT ON BREAST CANCER TREATMENT Read More
QCDx is a medical company that designs, manufactures, and provides solutions for detecting rare cells in blood circulation.
Our mission is to reveal circulating tumor cell heterogeneity early in cancer onset and throughout the disease trajectory to deliver precision cancer diagnosis that will guide the clinical oncologist to optimize treatment, monitor therapy, characterize metastasis and assess treatment toxicity.
Ultimately, improving patients' outcomes and quality of life.
Reveal cancer cells heterogeneity to guide therapy
bottom of page